Ed,
I think you have stated the case very clearly and fairly, and can only say "Ditto" to all except the last paragraph.
"I wish that fonix could be perceived as biotech and developmental stage drug firms have been perceived at their best..."
To accomplish that, fonix will have to submit its technology to open and critical review. Biotech and drug companies that I follow, even while they're still losing money, have a product (yes, that word again!) which has been studied in a number of scientific, objective, published trials in animals or a small number of humans. This is still long before FDA approval, but I and most other investors wouldn't think of investing in them if some of these studies aren't available. If fonix wishes to get to even that level (let alone sustainable profits), these open, objective trials need to be made available. The demo was the closest we've gotten so far, and was a flop.
Today's announcement may be a step on the path; maybe Oregon can carry out and publish such studies. But today's announcement, as you point out, is only that, it does not describe any new advance, or validate any current technology FOR THE SKEPTICS, who are unwilling to buy this stock just because Dr. Ashton, Siemens, or Oregon are involved anymore, but want/need some independent evidence which we can get our hands on, evaluate the validity of, etc. Only then will your wish come true, so I hope it's not something you expect to find in your stocking this Christmas!
Bob
By the way, Merry Christmas, if we don't correspond again before then!
PPS Maybe we're (the skeptics) wrong on insisting on this sort of evidence, if as Frank says, we don't grasp what fonix is all about. In that case, we'll miss the boat, and at least those of us who aren't short will simply see it as one missed opportunity among many. But your biotech analogy is a perfect way to illustrate that we treat all of our investments that way, not just fonix, and your statement that perception is crucial right now is right on the money. The skeptics are obviously in command for the moment. |